Related Experiment Video
Updated: Jun 25, 2026

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
Published on: February 16, 2024
Cell therapy for disorders of bone.
Reena Jethva1, Satoru Otsuru, Massimo Dominici
1Divisions of Human and Molecular Genetics, The Children's Hospital of Philadelphia, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.
Bone marrow transplantation shows promise for bone disorders by replacing deficient cells. Further research is needed to explore cell therapy
Area of Science:
- Regenerative Medicine
- Cell Biology
- Orthopedics
Background:
- Bone marrow transplantation (BMT) is a proven therapy for various diseases.
- Hematopoietic stem cells (HSC) are osteoclast precursors, and BMT improves osteopetrosis.
- The origin of osteoblasts is under investigation, with HSC and mesenchymal stromal cells (MSC) as candidates.
Purpose of the Study:
- To review cell therapy for genetic bone disorders and osteoporosis.
- To highlight progress and challenges in bone disorder cell therapies.
- To emphasize the need for understanding osteoblast origins for effective treatments.
Main Methods:
- Review of existing literature on cell therapy for bone disorders.
- Analysis of BMT in osteopetrosis.
- Discussion of HSC and MSC roles in bone metabolism.
Main Results:
- BMT has shown clinical improvement in osteopetrosis patients.
- HSC are confirmed osteoclast precursors.
- MSC and HSC are being investigated as osteoblast sources.
Conclusions:
- Cell therapy offers potential for long-term, curative benefits in bone disorders.
- Understanding osteoblast and osteoclast origins is key for developing new therapies.
- Careful consideration of BMT risks is necessary, but research is warranted.
More Related Videos
10:30Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications
Published on: December 8, 2016
11:22Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots
Published on: May 21, 2013
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Mesenchymal Stem Cells
Stem Cell Culture